Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements

European Heart Journal

Volumn 19, Issue 1, 1998, Pages 112-117

  Johansen, Odd ^a   Brekke, M ^a   Stromme J H ^a   Valen, V ^a   Seljeflot, I ^a   Skjaeggestad O ^a   Arnesen, H ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angioplasty; Creatine kinase MB; Myocardial injury; Troponin T

Indexed keywords

CREATINE KINASE MB; TROPONIN T;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; FEMALE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031891140     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0732     Document Type: Article

References (20)

1. [1] Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W. Enzyme linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Moll Cell Cardiol 1989; 21 1349-53.
2. [2] Katus HA, Remppis A, Neumann FJ et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-12.
3. [3] Mair J, Artner-Dworzak E, Lechleitner Å et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37: 845-52.
4. [4] Gerhardt W, Katus H, Ravkilde J et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of s-creatine kinase isoenyzme MB. Clin Chem 1991; 37: 1405-11.
5. [5] Katus HA, Remppis A, Scheffold T, Diederich K, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991; 67: 1360-7.
6. [6] Katus A, Scheffold T, Remppis A, Zehlein J. Proteins of the troponin complex. Lab Med 1992; 23: 311-17.
7. [7] Mair J, Wieser CH, Seibt I et al. Troponin T to diagnose myocardial infarction in bypass surgery. Lancet 1991; 347: 434.
8. [8] Eikvar L, Pillgram-Larsen J, Skjæggestad Ø, Arnesen H, Strømme JH. Serum cardio-specific troponin T after open heart surgery in patients with and without perioperative myocardial infarction. Scand J Clin Lab Invest 1994; 54: 329-35.
9. [9] Anonymous. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association. Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1988; 12: 529-45.
10. [10] Dorros G, Cowley MJ, Simpson J et al. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 1983; 67: 723-30.
11. [11] Report of the Fifth Working Group. Appendix II. 1971. World Health Organisation. Regional office for Europe. Copenhagen.
12. [12] Rothman K. Modern Epidemiology. Boston: Little Brown and Company, 1986.
13. [13] Hamm CW, Ravkilde J, Gerhardt W et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146-50.
14. [14] Gerhardt W, Ljungdahl L, Herbert AK. Troponin T and CK MB(Mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study 1992. Clin Biochem 1993; 26: 231-40.
15. [15] Apple FS. Acute myocardial infarction and coronary reperfusion. Clin Chem 1991; 97: 217-26.
16. [16] Neumeir D. Tissue specific distribution of creatine kinase isoenzymes. In: Lang H, ed. Creatine kinase isoenzymes. Heidelberg, NY: Springer, 1981: 85-109.
17. [17] Karim MA, Shinn M, Oskarsson H, Windle J, Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995; 76: 521-3.
18. [18] Ravkilde J, Nilssen H, Mickley H, Andersen PE, Thayssen Å, Hørder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 127: 13-20.
19. [19] Harrington R, Lincoff M, Califf R et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the coronary angioplasty versus excisional atherectomy trial (CAVIAT). J Am Coll Cardiol 1995; 25: 1693-9.
20. [20] Abdelmeguid A, Topol E, Whitlow P, Sapp S, Ellis G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528-36.